CH de la Côte Basque Bayonne

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation1 trial
• Coronary artery disease1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 32 trials

Status

• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• University Hospital, Brest2 trials

Running trials

• Recruiting

  AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

  NCT05198960· Phase 3· University Hospital, Brest· Source

  Contact: Frédéric BAUDUER, PH

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myeloproliferative neoplasms1 recruiting

Closed trials

• Terminated

  Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease

  NCT04217447· Phase 3· University Hospital, Brest· Source